Thu, January 4, 2024
Wed, January 3, 2024
Tue, January 2, 2024
Fri, December 29, 2023
Thu, December 28, 2023
Wed, December 27, 2023
Tue, December 26, 2023
Fri, December 22, 2023
Thu, December 21, 2023
Wed, December 20, 2023
Tue, December 19, 2023

Oren Livnat Maintained (zvra) at Strong Buy with Increased Target to $15 on, Dec 28th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-15-on-dec-28th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Oren Livnat of HC Wainwright & Co., Maintained "Zevra Therapeutics, Inc." (ZVRA) at Strong Buy with Increased Target from $10 to $15 on, Dec 28th, 2023.

Oren has made no other calls on ZVRA in the last 4 months.



There are 2 other peers that have a rating on ZVRA. Out of the 2 peers that are also analyzing ZVRA, 0 agree with Oren's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Oren


  • Jonathan Aschoff of "Roth MKM" Reiterated at Strong Buy and Held Target at $25 on, Friday, October 6th, 2023
  • Sumant Kulkarni of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $20 on, Friday, September 1st, 2023

Publication Contributing Sources